Weight Loss Drug Ads: Good or Bad?

This week, we analyze the remarkable marketing skills of one of the top music artists in the world - Taylor Swift.She has challenged the status quo at every turn - she regained ownership of her master recordings. She convinced Apple and Spotify to pay artists in a more equitable ...  Show more

This week, we go one toke over the line and look at the emerging world of cannabis marketing.We start with the question - just how does a plant become illegal?We'll explore the history of cannabis.We'll talk about which celebrities have their own brands (Hello Willie Nelson!)Whic ...  Show more

In this episode of The Oprah Podcast, Oprah sits down with Dr. Ania Jastreboff, an endocrinologist and associate professor at the Yale School of Medicine, to talk about the new GLP-1 medications like Ozempic, Wegovy, Mounjaro and Zepbound. Dr. Ania, who has been on the forefront ...  Show more

Has a name brand prescription medication ever shot to notoriety as quickly as Viagra did? Within a few months of its arrival on the market, it seems like everyone knew about the little blue pill, whether through commercials featuring celebrity spokespeople or from endless jokes o ...  Show more

News about weight-loss drugs is hard to miss. A new generation of drugs — Ozempic, Wegovy, Mounjaro, Zepbound — are on television, on billboards, and in many of our homes. There is little debate about the efficacy of the drugs for weight loss (they work, at least for most people) ...  Show more

Yes, drugs like Ozempic, Wegovy, and Mounjaro can help people lose weight, but at what cost? Dr. Sanjay Gupta explores why these drugs may not be the right fit for everyone. Learn more about your ad choices. Visit podcastchoices.com/adchoices